Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT04430933 is registered in ClinicalTrials.gov with NextCure, Inc. as lead sponsor.

NCT NCT04430933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04430933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
Lead sponsor
NextCure, Inc.
Phase
Phase 1/2
Overall status
Withdrawn
Start date
December 6, 2021
Completion date
October 30, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced or metastatic solid tumors, non-small cell lung cancer